chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient said she had rapid heart beats, pain near heart, fever, excessive swatting, dehydration, stomach ache for two days after taking the vaccine
At approximately the two week point post vaccine, I developed what is known as Moderna arm.   I reviewed available information about this on the internet and my symptoms correlated with what I had read.   Approximately 2/3 of my upper arm had a red rash.  It was warm, with minimal irritation.   Not painful.  No fever.  This lasted approximately 10 days, with slow resolution.  Other than some mild pain at injection site, this was the only symptom experienced.
Pt developed a hard knot on left arm, measuring 3in x 2in.  Along with the knot there was redness surrounding the knot, that was hot to the touch. Pt had a fever over 101 for three days. Provider drew a CBC when pt came back for nurse to look at the vaccine. Pt to following up in three days.
Larger erythematous area on (L) thigh, not tender, localized to area around vaccine, no pustules, or vesicles, no other lesions anywhere else, slightly warm.
Pain, redness, swelling, itching and heat at the injection site, PCP prescribed Prednisone and antihistamines. Instructed to go to ER if no improvement.
Menses started within 4 hours of vaccination outside normal cycle. Next morning upon awakening bumps/rash noted to back, abdomen, palms of hands, fingers and all four extremities,.
got an allergic reaction; Initial information received on 27-May-2022 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves an unknown age male patient who experienced got an allergic reaction while receiving vaccine DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect Daptacel (formulation, strength, dose, lot number, expiration date, route of administration and administration site: unknown) as prophylactic vaccination (immunization). Information regarding the batch number for this case was requested.   On an unknown onset and latency, the patient developed a non-serious got an allergic reaction (allergic reaction to excipient) following the administration of Daptacel.  It was reported that "Caller stated that her son got an allergic reaction, and she is trying to narrow down which ingredient of Dtap that might have caused it. She did not clarify if it was DAPTACEL and the call got disconnected due to bad reception before any contact information is collected. This is reported as a possible adverse event due to allergic reaction experienced by the patient."  Action taken: Not applicable.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Unknown for the event.
Had Flu symptoms 4 days after vaccination, soreness on the injection site and persisting up to this date.
fever, chills, cyanosis and numbness of lips and hands, dizziness and weakness
This spontaneous report was received from a physician concerning multiple unspecified patients of unknown age and gender. The patients' medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not reported. On unknown dates, the patients were vaccinated with improperly stored doses of RECOMBIVAX HB with lot # M037019 that has been verified to be valid, expiration date: 04-NOV-2018, via intramuscular, as prophylaxis (Strength and dose were not reported), which experienced a temperature excursion between 46 and 77 Fahrenheit degrees for 24 hours and between 32 and 36 Fahrenheit degrees for 419 hours and 30 minutes. There were no previous temperature excursions. Digital data logger was not involved. It was also reported that the patients were vaccinated with improperly stored doses of RECOMBIVAX HB via intramuscular as prophylaxis (Strength, dose, lot #, expiration date and dose were not reported), which experienced an unknown temperature excursion for an unknown time frame. There were no previous temperature excursions. Digital data logger was not involved. No adverse effects were reported. A product quality complaint was not involved. This is one of two reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1702USA000283.
Anything in it that could start my C. Diff again because I have been having Diarrhea; Anything in it that could start my C. Diff again because I have been having Diarrhea; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EN6205 and expiration date 30Jun2021), via an unspecified route of administration on 02Mar2021 13:30 at single dose for Covid-19 immunization. The patient's medical history included C. Diff. The patient's concomitant medications were not reported. It was reported that patient got shot of vaccine on 02Mar2021 13:30 Tuesday and have a question, I have C. diff and never ask before that's only question and I wish to have asked my doctor but I wanted to know if this could start, was there anything in it that could start my C. Diff again because I have been having diarrhea.  The patient further stated "Is something to do with the Colon, it's a diarrhea type disease Is there something in the medication. It's an antibiotic (further clarification unknown hence captured as unspecified antibiotic), I cannot have it, I think.". "I have had the shot already but I got the diarrhea and I wanted to know if C.Diff is a part of this like I could get something from this shot, antibiotic or whatever because I cannot have that". "If I call my Doctor would my Doctor know if that could cause the problem that I have." The patient stated that), I could not have an antibiotic because they were afraid that I will get C. Diff again (further clarification unknown hence captured as unspecified antibiotic). They had a terrible time with me so I can't have any antibiotic." The outcome of the events was unknown.
Patient received ZOSTAVAX on 4-21-12 and reported to the pharmacy a week later complaining of a rash, redness at injection site. Patient stated the redness occurred the next day but is improving. Patient advised to keep watching the area and seek medical attention if worsens.
First injection: 1 hour after injection, pain in left knee and down to ankle. Felt as though metal rod was through knee; knee arthritic; This is a spontaneous report from a contactable consumer (patient) reported for self. A 70-year-old female patient (no pregnant) received her first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EM), via an unspecified route of administration at left arm at the age of 70-year-old, on 15Jan2021 11:30 at single dose for covid-19 immunisation. Medical history included bulging discs and allergies to penicillin. Concomitant medication included ascorbic acid (Vitamin C), colecalciferol (VITAMIN D), calcium, magnesium, biotin, curcuma longa (TURMERIC). The patient previously took hydromorphone hydrochloride (DILAUDID) and experienced allergies, sulphur and experienced allergies. One hour after first injection in left arm (15Jan2021 12:30 P.M), pain in left knee and down to ankle. Felt as though metal rod was through knee. Wore compression socks and a knee brace and did RICE to ease discomfort. At this report (2021) the patient felt knee arthritic since vaccine although intense pain subsided. No other vaccine received in four weeks. No COVID prior vaccination. No COVID tested post vaccination. The adverse events resulted in disability. The outcome of events was recovered with lasting effects.  Information on the Lot/batch number has been requested.
Left arm swelled, hot to touch, numbness and tingling in left hand likely due to swelling, treated at Urgent Care, given steroids, anti-inflammatories, and ice, symptoms subsided by 9 pm same day.
INFLAMED TONSILS; SORE THROAT; This spontaneous case was reported by a consumer and describes the occurrence of TONSILLAR INFLAMMATION (INFLAMED TONSILS) and OROPHARYNGEAL PAIN (SORE THROAT) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Panuveitis.    Concomitant products included METHOTREXATE for an unknown indication.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (unknown route) Citrate free; Solution for injection in pre-filled pen. On an unknown date, the patient experienced TONSILLAR INFLAMMATION (INFLAMED TONSILS) and OROPHARYNGEAL PAIN (SORE THROAT). At the time of the report, TONSILLAR INFLAMMATION (INFLAMED TONSILS) outcome was unknown and OROPHARYNGEAL PAIN (SORE THROAT) had resolved.            No concomitant medications were reported.  It was unknown if the patient was enrolled in a COVID-19 vaccine trial.  The reporter causality for the events with HUMIRA was not reported.  No treatment information was reported.
I woke up with sore inflamed right arm.Slight headache ,fever and chills. Took some Tylenol 2 tabs of 325mg tabs.
Myalgia chills, then hot Narrative:  Myalgia, chills, then hot. Recovered within 24 hours.
No additional information; MMRII dose that was administered 4 days after expiration; This spontaneous report as received from a registered nurse refers to a 30-year-old female patient.There was no information about the patient's medical history, concurrent conditions or concomitant medication.  Historical vaccine include a COVID 19 Vaccine administered on 17-NOV-2021.  On 08-DEC-2021, the patient was vaccinated with an expired second dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II)rHA, lot # S039312, expiration date: 04-DEC-2021, subcutaneous in the right arm for prophylaxis (dose unspecified)( expired product administered) at public health clinical/hospital. The dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) had no previous temperature excursions. No product quality complaint was involved. No additional information.
pain/jabbing/pain all over her body. Like a knife all over her body; low-grade fever; chills; tremors; couldn't walk; loss of balance; headache; neck pain; it was more severe; couldn't get up; not even to go to the bathroom; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), in 2022 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; Unknown manufacturer, previously experienced some reactions with the previous doses), for COVID-19 Immunization, reaction(s): "reactions with the previous doses". The following information was reported: CHILLS (non-serious) with onset 2022, outcome "unknown"; LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (non-serious) with onset 2022, outcome "unknown", described as "couldn't get up; not even to go to the bathroom"; GAIT DISTURBANCE (non-serious) with onset 2022, outcome "unknown", described as "couldn't walk"; HEADACHE (non-serious) with onset 2022, outcome "unknown"; CONDITION AGGRAVATED (non-serious) with onset 2022, outcome "unknown", described as "it was more severe"; BALANCE DISORDER (non-serious) with onset 2022, outcome "unknown", described as "loss of balance"; PYREXIA (non-serious) with onset 2022, outcome "unknown", described as "low-grade fever"; NECK PAIN (non-serious) with onset 2022, outcome "unknown"; PAIN (non-serious) with onset 2022, outcome "unknown", described as "pain/jabbing/pain all over her body. Like a knife all over her body"; TREMOR (non-serious) with onset 2022, outcome "unknown", described as "tremors".  Additional information:-As per transferring agent caller would like to know if the reactions she reported are unusual. She had previously experienced some reactions with the previous doses, but now it was more severe. Caller confirms the previous information. Patient got the booster dose on Thursday. She couldn't get up, not even to the bathroom Patient was very active person, she can't go to the bathroom because she didn't moved around. It's not the first time it happened to the patient many times, but this time it was more severe. her friends, her husband, her family had suffered it but they didn't react like that. Caller would like to know if her symptoms were usual. AE - E-transfer to agent that it may possibly duplicated.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Approximately 12 days s/p vaccines patient developed fever approximately 104 & associated febrile seizure. Rash noted next day with diarrhea.
On 12/31/99, the pt experienced varicella, mostly in the upper portion of the body. Another pt was reported with a similar experience after vax. No further information is available.
Few hours after starting VIVOTIF  - developed a maculopapular rash over face/trunk/Ext. No facial swelling. No dizziness. No SOB.
Three vaccines placed in arm with erythema/induration/ pain starting the following day. By 48hours pt had cellulitis.
Hives all over the body and inside mouth and throat. Shortness of breath and pressure on my lungs.
ARM SORE; BODY ACHES; CHILLS; BAD HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, the subject experienced arm sore. On APR-2021, the subject experienced body aches. On APR-2021, the subject experienced chills. On APR-2021, the subject experienced bad headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the bad headache, arm sore, body aches and chills was not reported. This report was non-serious.
Patient went to urgent care today due to swelling of arm and was told she had cellulitis in right arm (same arm PNEUMOVAX was given). Patient was given Rx for cephalexin 500 mg capsule every 8 hours for 10 days.
Had a rapid heart rate.  It was at 100 bpm or higher while resting.  Stayed at that rate for about 24 hours and then dropped to about 90.  My normal heart rate is below 80 (sometimes lower than 70).  Still not completely back to normal, but coming down.
Red rash on neck. Left side; This is a spontaneous report from a non-contactable consumer (patient). An adult male patient of unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: En6206) via an unspecified route of administration in the left arm on 18Mar2021 at 09:30 as 1st dose, single dose for COVID-19 immunization. The patient did not had any medical history. Concomitant medication were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. Since the vaccination, the patient had not tested for COVID-19. On 18Mar2021, about 5 hours after the shot, the patient experienced red rash (reported as red rush) on the left side of the neck. The patient did not receive any treatment for the event. The clinical outcome of the event red rash on the left side of the neck was unknown.   No follow-up attempts are possible. No further information is expected since reporter is non-contactable.  Amendment: This follow-up report is being submitted to amend previously reported information: 1. patient's initial should be captured separately as first name and last name in general tab.  2. patient's initial added in first name field in patient tab. 3."Relevant medical history-None" was added in other relevant history tab since Relevant medical history and concurrent conditions is provided as No. 4.Treatment Received ticked as No. 5. final sentence should be No follow-up attempts are possible. No further information is expected since reporter is non-contactable. 6.Concomitant therapy leave blank since no information provided about the concomitant drug. 7. adverse_event_start_time: 03:00 AM provided in source document.
Patient is going to come into office and going to receive the right vaccine. patient well talk with provider.
Chills,  body aches, fatigue, nausea, dizziness,  the injection site reaction including redness, swelling, pain, muscle hardness
ACUTE ON CHRONIC RESPIRATORY FAILURE ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE
pt.recvd dose M-M-R II & exp. "mumps-like synd".
Information has been received from a physician referring to a patient of unknown age and gender. Information about medical history, concurrent condition and concomitant medication was not reported. On 21-OCT-2015 the patient was vaccinated with a dose of improperly stored oral, ROTATEQ (lot # L008031 with expiration date of 03-AUG-2016; strength, dosage and frequency unspecified) orally (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Pink and "a little itchy" area; Pink and "a little itchy" area; This spontaneous case was reported by a consumer and describes the occurrence of SKIN DISCOLOURATION (Pink and "a little itchy" area) and PRURITUS (Pink and "a little itchy" area) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 015M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Mar-2021, the patient experienced SKIN DISCOLOURATION (Pink and "a little itchy" area) and PRURITUS (Pink and "a little itchy" area). At the time of the report, SKIN DISCOLOURATION (Pink and "a little itchy" area) and PRURITUS (Pink and "a little itchy" area) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Feb-2021, Biopsy skin: (Negative) Negative.
Several health care employees were vaccinated with one dose of rubella virus vaccine live.  Subsequently the pts sought medical attention and serum rubella antibody tests revealed negative rubella titers.
Thrombosis; This is a spontaneous report from a Pfizer Sponsored Program, received from a non-contactable consumer (patient). A male patient of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), on unspecified date as dose number unknown, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Caller (patient) stated that he would like to make a claim against Pfizer for money because he took the CVOID vaccine and 3 months later he had to go to the emergency room with a thrombosis. Caller wondering if people have been calling with this issue after taking the vaccine. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information expected.
bad headache that felt like migraine; bad headache that felt like migraine; thought it might be a sinus headache; pain on the right side of the back of her neck that radiated behind her right eye; pain on the right side of the back of her neck that radiated behind her right eye; dizziness; sweating; swollen lymph nodes in her throat; This is a spontaneous report from a contactable consumer (patient). A 48-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: not reported), via an unspecified route of administration on 15Jan2021 at 07:00 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 15Jan2021, the patient experienced dizziness, sweating, and swollen lymph nodes in her throat. On 18Jan2021, the patient started to get a really bad headache that felt like migraine and thought it might be a sinus headache. On the same day, the patient also had pain on the right side of the back of her neck that radiated behind her right eye. The patient would like to know if she could take anything for her headache. The outcome of the event bad headache that felt like migraine was not recovered while the other events was unknown.  Information about lot/batch number has been requested.
Elevated temperature of 102.6F, 3 hours, post vax. Also had a headache, muscle aches all over the body, joint pain and nausea but no vomiting or diarrhea. Became ill on 9/12/00, seen in clinic on 9/18/00. Generalized aching gradually disappeared 5 weeks, post vax. Fever and other symptoms were resolved in 1-1 1/2 weeks.
Experiencing on and off chest pain; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP).  A 74 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1, SINGLE, MANUFACTURER UNKNOWN.), for COVID-19 immunisation. The following information was reported: CHEST PAIN (non-serious), outcome "unknown", described as "Experiencing on and off chest pain".  Additional Information: This consumer (patient's daughter) reported for a 74-year-old female patient that: Daughter of the patient reported an event for Comirnaty. The daughter mentioned that following 2nd dose of Comirnaty, the patient has been experiencing on and off chest pain. No further details provided, no consent for follow-up.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
History of presenting illness: Reports they received MMR and Varicella vaccines 9 days back for thee 1 yr WCC and now has developed rash and fever. Rash started 07/18/2018, started from neck and then progressed down to involve the whole body. T-max of 101 F 2 days before the onset of rash.
1 day after vaccine arm was swollen hard, red, painful and hot from shoulder to elbow.
pt recvd & 4 hrs p/vax exp nausea, vomiting, fever, chills, lightheadedness;
1-2 hrs after receiving H1N1 vaccine pt. developed itching took BENADRYL for hives - went to ER- prednisone taper x 1 wk - 2/2/10 - resolved - denies egg allergy